Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 11:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 745–768 of 17,841 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Patient Control Clear all

Conditions: Vasospasm, Intracranial, Subarachnoid Hemorrhage
Interventions: Extraventricular Drain, Lumbar Drain; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 110 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Breast Cancer
Interventions: contract-enhanced MRI, Unilateral Adjuvant Radiation Therapy; Procedure · Radiation
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years to 90 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Single Ventricle Defect
Interventions: Not listed
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 4 Months to 10 Years
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV Infections
Interventions: Tetanus Toxoid Vaccine, Indinavir sulfate, Lamivudine/Zidovudine, Ritonavir, Abacavir sulfate, Amprenavir, Efavirenz, Hepatitis B Vaccine (Recombinant), Lamivudine, Zidovudine; Biological · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 16 Years and older
Enrollment: 288 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 1999
U.S. locations: 11
States / cities: San Francisco, California • Chicago, Illinois • Boston, Massachusetts + 6 more

Conditions: Lumbar Osteoarthritis, Spondylosis, Lumbar Disc Disease, Spinal Stenosis
Interventions: Ketorolac, Acetaminophen, Placebo; Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 75 Years
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Burns
Interventions: Fish skin, Cadaver skin; Device
Lead sponsor: Kerecis Ltd.; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: B-cell Chronic Lymphocytic Leukemia
Interventions: Lenalidomide, Placebo; Drug
Lead sponsor: Celgene; Industry
Eligibility: 18 Years and older
Enrollment: 317 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2020
U.S. locations: 56
States / cities: Phoenix, Arizona • Fountain Valley, California • San Diego, California + 48 more

Conditions: Hypertension, Cardiovascular Disease
Interventions: HBPM+website+patient navigator; Behavioral
Lead sponsor: Memorial Hospital of Rhode Island; Other
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Pawtucket, Rhode Island

Conditions: Type 1 Diabetes,, Bone
Interventions: Not listed
Lead sponsor: Creighton University; Other
Eligibility: 19 Years to 50 Years
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Fracture, Fractures, Bone, Fractures, Closed, Fractures, Open
Interventions: FastFrame External Fixation System - Knee Spanning or Damage Control Kit; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Periodontal Diseases, Periodontitis, Apical, Chronic Nonsuppurative, Suppuration of Gingival Crevice
Interventions: Scaling and Root Planing, Diode Laser + Scaling and Root Planing; Procedure
Lead sponsor: University of Nebraska; Other
Eligibility: 30 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Primary Hypertension
Interventions: LY2623091, Tadalafil, Spironolactone, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 33
States / cities: Glendale, Arizona • Concord, California • Encinitas, California + 28 more

Conditions: Pulmonary Hypertension
Interventions: Riociguat (Adempas, BAY63-2521), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 262 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 9
States / cities: La Jolla, California • Sacramento, California • Miami, Florida + 6 more

Conditions: Amputation, Upper Limb
Interventions: Glide, Direct Control; Device
Lead sponsor: Infinite Biomedical Technologies; Industry
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Redondo Beach, California

Conditions: Mohs Micrographic Surgery
Interventions: 3D printed model, Verbal Counselling; Behavioral
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Diabetes Mellitus, Type 2
Interventions: Digital health Partnership program; Behavioral
Lead sponsor: Evidation Health; Industry
Eligibility: 18 Years and older
Enrollment: 624 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: San Mateo, California

Conditions: Sleep Apnea, Sleep Disordered Breathing
Interventions: CPAP machine with MNT algorithm; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis of the Knee
Interventions: REGN475, Placebo; Drug · Other
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 3
States / cities: Anaheim, California • Tampa, Florida • Salt Lake City, Utah

Conditions: Pain Management, Spinal Fusion, Scoliosis
Interventions: Intrathecal morphine, Extended Release Epidural Morphine; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 8 Years to 17 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Critical Illness, Anxiety, Respiratory Failure
Interventions: Dexmedetomidine; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Rochester, Minnesota

Conditions: Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions: LCQ908, placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 11
States / cities: Mobile, Alabama • San Diego, California • Gainesville, Florida + 8 more

Conditions: Asthma
Interventions: Intervention: Budesonide, Usual care: albuterol + systemic steroids; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 1 Year to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute Heart Failure
Interventions: Cinaciguat (BAY58-2667), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 6
States / cities: Ridgewood, New Jersey • Winston-Salem, North Carolina • Cleveland, Ohio + 2 more

Conditions: Paroxysmal Atrial Fibrillation
Interventions: cryoballoon ablation, Radiofrequency ablation; Procedure
Lead sponsor: Meshalkin Research Institute of Pathology of Circulation; Network
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage

The Effects of Radiation in Reconstructed Breasts

Cerebral Blood Flow in Single Ventricles Throughout Staged Surgical Reconstruction

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes

Fish Skin Compared to Cadaver Skin as Temporary Cover for Full Thickness Burns

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

Pilot Study of Home Blood Pressure Control Program (eBP Control)

Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls

FastFrame Knee Spanning and Damage Control Kit PMCF

Diode Laser Study for Periodontal Maintenance Patients

A Study of LY2623091 in Participants With High Blood Pressure

A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.

Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses

3D Printed Models in Mohs Micrographic Surgery

Diabetes Coaching Program for Medicare Advantage Members With Type 2 Diabetes - Impact on A1c

Multinight CPAP for Sleep Apnea Patients

A Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Osteoarthritis of the Knee

Intrathecal Morphine Versus Epidural Extended Release Morphine for Pediatric Patients Undergoing Spinal Fusion

Self-management of Sedative Therapy by Ventilated Patients

Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients

Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department

BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Cryoballoon Ablation of Pulmonary Veins After Failed RF Ablation in Patients With Paroxysmal AF